Cibc Private Wealth Group, LLC Guardant Health, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.4 Billion
- Q2 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 544 shares of GH stock, worth $14,573. This represents 0.0% of its overall portfolio holdings.
Number of Shares
544
Previous 576
5.56%
Holding current value
$14,573
Previous $11,000
36.36%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GH
# of Institutions
331Shares Held
116MCall Options Held
680KPut Options Held
1.66M-
Vanguard Group Inc Valley Forge, PA11.6MShares$312 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$301 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$163 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.5MShares$121 Million4.27% of portfolio
-
Capital International Investors Los Angeles, CA4.47MShares$120 Million0.03% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.74B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...